View More Recent Stories

Jul 31, 2025 02:49PM Cells: Hemostemix ACP-01 Provides the Scientific Basis for Improving the Longevity and Signal Uptake of Brain Computer Implants
Jul 24, 2025 10:24AM Hemostemix Closes $2,969,600 Private Placement
Jul 23, 2025 08:55AM Hemostemix Closes Sale of 23rd ACP-01 Therapy Convertible Debenture
Jul 17, 2025 04:10PM Hemostemix Closing $3,000,000 Private Placement
Jul 9, 2025 11:00AM Hemostemix Oversubscribed, Closing $2,700,000 Private Placement and Settles $400,000 of Debt at $0.20 per Share
Jul 4, 2025 08:20AM Hemostemix Closes $469,366 Private Placement
Jul 3, 2025 10:16AM Hemostemix Announces its 10th Publication: A Molecular Strategy for the Treatment of Heart Failure: Response to BioCardia's Cardiamp Heart Failure Trial
Jul 2, 2025 03:00AM Hemostemix's VesCell Sales are Legal in Florida as it Pivots to Allow Non-FDA Approved Stem Cell Treatments!
Jun 27, 2025 11:54AM Croom Lawrence Joins Hemostemix with Revenue Share Agreement and VesCell.Health Launch
Jun 26, 2025 09:00AM Hemostemix Announces Lead Order of $1,500,000 and the Full Repayment of $2,500,000 Convertible Debenture
Jun 17, 2025 08:41AM Hemostemix Closes Private Placement of $469,366
May 20, 2025 09:00AM Hemostemix Presents at TERMIS 2025, Freiburg, Germany
May 12, 2025 09:00AM Hemostemix Closes Private Placement of USD $336,500 at $0.295 per Share
May 8, 2025 09:12AM Hemostemix at Invest Stuttgart
Apr 23, 2025 11:53AM Hemostemix Engages PatentVest to Strengthen its Global Patent Portfolio
Mar 17, 2025 10:28AM Hemostemix's Pitch to Wall Street: ACP-01 Vascular Dementia Trial will Generate $5,365,000, Capture Data, as a Phase 1 Clinical Trial
Mar 6, 2025 07:30AM Hemostemix and FireFly Neuroscience's Brain Network Analytics (BNA(TM)) Engage to Complete Phase 1 Vascular Dementia Clinical Trial of ACP-01
Mar 5, 2025 07:45AM Hemostemix Sells Its 23rd ACP-01 Therapy Convertible Debenture
Feb 20, 2025 06:05AM RETRANSMISSION: Hemostemix Licenses CytoImmune's BioReactor Technologies
Feb 19, 2025 03:24PM Hemostemix Licenses CytoImmune's BioReactor Technologies
Feb 13, 2025 08:09PM Hemostemix Provides Corporate Update
Feb 11, 2025 09:43AM Hemostemix PR Inc. Congratulates Luis Munoz Marin International Airport on Achieving CEIV Pharma Certification
Feb 10, 2025 10:48AM Hemostemix Contracts ProConsul to Ramp up Engagement with New Investors
Jan 27, 2025 02:37PM Hemostemix Up-lists to TradeGateExchange in Germany
Jan 23, 2025 08:27AM Hemostemix Up-Lists to OTCQB While it Presents its Global Scale-Up Strategy at Two Investor Conferences in Puerto Rico
Jun 11, 2024 11:06AM Hemostemix Announces Trademark Granted by Switzerland and Interest Payment
View More Recent Stories